EXOSOME DIAGNOSTICS
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

EXOSOME DIAGNOSTICS Trademark

Serial Number: 86724917

EXOSOME DIAGNOSTICS is a trademark filed by Exosome Diagnostics, Inc. on August 14, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Exosome Diagnostics, Inc. (18 trademarks)

Lasker Biomedical Research Building
New York, NY 10032

Entity Type: 03

Trademark Details

Filing Date

August 14, 2015

Registration Date

Not Registered

Goods & Services

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Huntington's disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Parkinson's disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer's disease

Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases; medical testing for diagnostic or treatment purposes in the field of Huntington's disease; medical testing for diagnostic or treatment purposes in the field of Parkinson's disease; medical testing for diagnostic or treatment purposes in the field of Alzheimer's disease; liquid biopsy testing for medical purposes

Providing clinical laboratory test services for others for scientific research purposes; providing clinical scientific laboratory services for others according to the clinical laboratory improvement amendments (CLIA) program

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 2, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 2, 2018 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 11, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 11, 2016 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2015 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2015 NWOS
NEW APPLICATION ENTERED
Aug 18, 2015 NWAP